Event

30.08.2014 - 04.09.2014, Paris (F)

FEBS-EMBO 2014 Conference

The FEBS–EMBO 2014 Conference will be a unique international event that brings together many leading researchers to discuss the latest scientific findings in the life sciences. Scientists from across the world will be able to attend a jointly organized conference that offers unparalleled scope for the entire range of the molecular life sciences. The conference will also celebrate the 50th anniversaries of FEBS and EMBO and the 100th anniversary of the French Society for Biochemistry and Molecular Biology.
Kontakt:
communications@embo.org

www.embo.org

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/service/events/pos/3.html?cHash=bef2e90a642998c7c207ba06434dd39b&events%5Buid%5D=4530

Whitepaper

Video

All videos

Product of the week

Products

Events

All Events

Stock list

All quotes

TOP

  • CHRONTECH PHARMA (S)0.02 SEK100.00%
  • ERYTECH PHARMA (F)39.50 EUR9.45%
  • PAION (D)2.69 EUR8.47%

FLOP

  • BAVARIAN NORDIC (D)40.26 EUR-10.69%
  • ZELTIA (E)3.69 EUR-8.44%
  • TIGENIX (B)0.73 EUR-7.59%

TOP

  • CHRONTECH PHARMA (S)0.02 SEK100.0%
  • DBV TECHNOLOGIES (F)81.03 EUR53.6%
  • IXICO (UK)34.00 GBP41.7%

FLOP

  • BIOTEST (D)27.24 EUR-60.8%
  • BIOTECH PHARMACON (N)9.43 NOK-46.1%
  • TRANSGENE (F)2.80 EUR-23.9%

TOP

  • ADOCIA (F)88.74 EUR531.6%
  • DBV TECHNOLOGIES (F)81.03 EUR325.4%
  • FORMYCON (D)28.70 EUR321.4%

FLOP

  • CHRONTECH PHARMA (S)0.02 SEK-77.8%
  • NEUROVIVE PHARMACEUTICAL AB (S)22.70 SEK-71.8%
  • NEOVACS (F)1.01 EUR-70.6%

No liability assumed, Date: 04.08.2015

Current issue

All issues